STAT of the union: Dynamics of distinct tumor-associated macrophage subsets governed by STAT1

European Journal of Immunology

Volumn 44, Issue 8, 2014, Pages 2238-2242

  Van Overmeire, Eva ^a,b   Laoui, Damya ^a,b   Keirsse, Jiri ^a,b   Bonelli, Stefano ^a,b   Lahmar, Qods ^a,b   Van Ginderachter, Jo A ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

CSF 1; Ontogeny; Stat1; Tumor associated macrophages

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR 1; GLYCOPROTEIN; HISTIDINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT1 PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANGIOGENESIS; BLOOD; BLOOD VESSEL; BONE MARROW CELL; BREAST CANCER; BREAST CARCINOMA; BREAST TUMOR; CANCER GRAFT; CELL PROLIFERATION; CONFOCAL MICROSCOPY; GENE EXPRESSION; HELMINTHIASIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LUNG CARCINOMA; MACROPHAGE; MACROPHAGE ACTIVATION; METASTASIS; MOLECULAR IMAGING; MOLECULE; MONOCYTE; MUSCLE INJURY; MYOMETRIUM; NONHUMAN; NOTE; ONCOGENE; PHAGOCYTE; PHAGOCYTOSIS; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; SUPPRESSOR CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; TUMOR RECURRENCE; UTERUS;

CSF-1; ONTOGENY; STAT1; TUMOR-ASSOCIATED MACROPHAGES;

BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENES, MHC CLASS II; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MONOCYTES; RECEPTOR, ERBB-2; STAT1 TRANSCRIPTION FACTOR;

EID: 84906082665     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444870     Document Type: Note

References (33)

1. Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M. et al., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006. 313: 1960-1964.
2. Zhang, Q.-W., Liu, L., Gong, C.-Y., Shi, H.-S., Zeng, Y.-H., Wang, X.-Z., Zhao, Y.-W. et al., Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS ONE 2012. 7: e50946.
3. De Palma, M. and Lewis, C. E., Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013. 23: 277-286.
4. Chao, M. P., Alizadeh, A. A., Tang, C., Myklebust, J. H., Varghese, B., Gill, S., Jan, M. et al., Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 2010. 142: 699-713.
5. Weiss, J. M., Ridnour, L. A., Back, T., Hussain, S. P., He, P., Maciag, A. E., Keefer, L. K. et al., Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J. Exp. Med. 2010. 207: 2455-2467.
6. Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L. et al., HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 2011. 19: 31-44.
7. Casazza, A., Laoui, D., Wenes, M., Rizzolio, S., Bassani, N., Mambretti, M., Deschoemaeker, S. et al., Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell 2013. 24: 695-709.
8. Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M. et al., Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010. 70: 5728-5739.
9. Movahedi, K., Schoonooghe, S., Laoui, D., Houbracken, I., Waelput, W., Breckpot, K., Bouwens, L. et al., Nanobody-based targeting of the Macrophage Mannose Receptor for effective in vivo imaging of tumor-associated macrophages. Cancer Res. 2012. 72: 4165-4177.
10. Laoui, D., Van Overmeire, E., Di Conza, G., Aldeni, C., Keirsse, J., Morias, Y., Movahedi, K. et al., Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population. Cancer Res. 2014. 74: 24-30.
11. Tymoszuk, P., Evens, H., Marzola, V., Wachowicz, K., Wasmer, M. H., Datta, S., Müller-Holzner, E. et al., In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors. Eur. J. Immunol. 2014. 44: 2247-2262.
12. Sieweke, M. H. and Allen, J. E., Beyond stem cells: self-renewal of differentiated macrophages. Science 2013. 342: 946-953.
13. Kuang, D.-M., Wu, Y., Chen, N., Cheng, J., Zhuang, S.-M. and Zheng, L., Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 2007. 110: 587-595.
14. low mediates tumor progression in mice. BMC Immunol. 2011. 12: 43.
15. Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J- F., Goswami, S., Stanley, E., Segall, J. E. et al., Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 2007. 67: 2649-2656.
16. Egeblad, M., Ewald, A. J., Askautrud, H. A., Truitt, M. L., Welm, B. E., Bainbridge, E., Peeters, G. et al., Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy. Dis. Model Mech. 2008. 1: 155-167.
17. Mazzieri, R., Pucci, F., Moi, D., Zonari, E., Ranghetti, A., Berti, A., Politi, L. S. et al., Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 2011. 19: 512-526.
18. Welford, A. F., Biziato, D., Coffelt, S. B., Nucera, S., Fisher, M., Pucci, F., Di Serio, C. et al., TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. J. Clin. Invest. 2011. 121: 1969-1973.
19. Schouppe, E., Mommer, C., Movahedi, K., Laoui, D., Morias, Y., Gysemans, C., Luyckx, A. et al., Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8 +T-cell activation events. Eur. J. Immunol. 2013. 43: 2930-2942.
20. Hannesdóttir, L., Tymoszuk, P., Parajuli, N., Wasmer, M. H., Philipp, S., Daschil, N., Datta, S. et al., Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response. Eur. J. Immunol. 2013. 43: 2718-2729.
21. Mossadegh-Keller, N., Sarrazin, S., Kandalla, P. K., Espinosa, L., Stanley, E. R., Nutt, S. L., Moore, J. et al., M-CSF instructs myeloid lineage fate in single haematopoietic stem cells. Nature 2013. 497: 239-243.
22. Tagliani, E., Shi, C., Nancy, P., Tay, C.-S., Pamer, E. G. and Erlebacher, A., Coordinate regulation of tissue macrophage and dendritic cell population dynamics by CSF-1. J. Exp. Med. 2011. 208: 1901-1916.
23. Jenkins, S. J., Ruckerl, D., Thomas, G. D., Hewitson, J. P., Duncan, S., Brombacher, F., Maizels, R. M. et al., IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J. Exp. Med. 2013. 210: 2477-2491.
24. Côté, C.H., Bouchard, P., van Rooijen, N., Marsolais, D. and Duchesne, E., Monocyte depletion increases local proliferation of macrophage subsets after skeletal muscle injury. BMC Musculoskelet. Disord. 2013. 14: 359.
25. Zhang, M.-Z., Yao, B., Yang, S., Jiang, L., Wang, S., Fan, X., Yin, H. et al., CSF-1 signaling mediates recovery from acute kidney injury. J. Clin. Invest. 2012. 122: 4519-4532.
26. Robbins, C. S., Hilgendorf, I., Weber, G. F., Theurl, I., Iwamoto, Y., Figueiredo, J.-L., Gorbatov, R. et al., Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 2013. 19: 1166-1172.
27. Campbell, M. J., Tonlaar, N. Y., Garwood, E. R., Huo, D., Moore, D. H., Khramtsov, A. I., Au, A. et al., Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res. Treat. 2011. 128: 703-11.
28. Pahler, J. C., Tazzyman, S., Erez, N., Chen, Y.-Y., Murdoch, C., Nozawa, H., Lewis, C. E. et al., Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia 2008. 10: 329-340.
29. Cortez-Retamozo, V., Etzrodt, M., Newton, A., Rauch, P. J., Chudnovskiy, A., Berger, C., Ryan, R. J. et al., Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. USA 2012. 109: 2491-2496.
30. Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A. et al., CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011. 475: 222-225.
31. Sanford, D. E., Belt, B. A., Panni, R. Z., Mayer, A., Deshpande, A. D., Carpenter, D., Mitchem, J. B. et al., Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clin. Cancer Res. 2013. 19: 3404-3415.
32. Fleetwood, A. J., Lawrence, T., Hamilton, J. A. and Cook, A. D., Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 2007. 178: 5245-5252.
33. Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C. et al., CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 2013. 19: 1264-1272.